MTSC | 27 Nov 2018

London’s pioneering MedTech accelerator launches at Imperial

An Imperial-led programme to boost the commercialisation of new medical technologies by early career researchers has welcomed its first cohort.

The MedTech SuperConnector is a new entrepreneurial training programme for Early Career Researchers to help them translate their discoveries into new diagnostic tools, medical devices and digital healthcare solutions.

Supported by a £5m grant from Research England, the SuperConnector is an Imperial led consortium involving seven partner institutions: Queen Mary University of London, Bucks New University, The Francis Crick Institute, Royal College of Art, Royal College of Music, Institute of Cancer Research and Royal Veterinary College.

From ground-breaking advances in prosthesis to new clinical applications for machine learning, the programme will provide ten participants with funding, training, mentorship and access to industry partners and patients to help them fast-track the commercialisation of their research.

The MedTech Superconnector forms part of Imperial’s expanding entrepreneurial ecosystem to support staff and students in translating their research into benefits for society. It builds on the College’s Techcelerate programme for postdocs that supported 14 researchers to leave their labs for 3 months earlier this year and pursue their business ideas.

by Deborah Evanson

Article text (excluding photos or graphics) © Imperial College London.

Photos and graphics subject to third party copyright used with permission or © Imperial College London.